Nuvation Bio NUVB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License | $99.87M+811% | $38.24M+386% | $17.79M— | $13.12M— | $10.96M— | |
| Product Revenue | $42.8M— | $25.1M— | —— | —— | —— | |
| Royalty Revenue | $2.2M— | $1M— | —— | —— | —— | |
| Revenue by Geography | ||||||
| CN | $11.7M+45.4% | $9.41M+82.8% | $12.43M— | $10.31M— | $8.05M— | |
| JP | $29.3M+907% | $28.83M+958% | $5.36M— | $2.81M— | $2.91M— | |
| US | $102.05M— | $24.66M— | $8.96M— | $1.24M— | —— | |
| Area Of Real Estate Property by Geography | ||||||
| CN | $7.07K+6.5% | $7K+8.1% | $6.94K— | $6.79K— | $6.63K— | |
| MA | $8.94K— | $8.94K— | $8.94K— | $8.94K— | —— | |
| New York City | $31.6K0.0% | $31.6K0.0% | $31.6K0.0% | $31.6K0.0% | $31.6K0.0% | |
| San Francisco | $77.67K-12.8% | $77.67K-18.1% | $77.67K-22.8% | $83.39K-17.1% | $89.11K-0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Nuvation Bio break its business down?
- Nuvation Bio (NUVB) reports revenue by product across 4 parts — License, Product Revenue, Research And Development Service Revenue and Royalty Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Nuvation Bio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Nuvation Bio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.